SCHEMBL9761035

SCHEMBL9761035

O=C(c1ccccc1)c1ccc2[nH]c(=O)n(Cc3ccccc3)c(=O)c2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.62
HPGD P15428 6/20 0.62
KDM4E B2RXH2 5/20 0.62
SMN1; SMN2 Q16637 4/20 0.62
LMNA P02545 8/20 0.53
MAPK10 P53779 4/20 0.53
NPSR1 Q6W5P4 4/20 0.53
HSD17B10 Q99714 3/20 0.53
USP2 O75604 3/20 0.53
MAPT P10636 4/20 0.53
HDAC1 Q13547 1/20 0.52
KMT2A Q03164 4/20 0.51
MEN1 O00255 3/20 0.51
POLB P06746 2/20 0.50
TP53 P04637 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HTT P42858 3/20 0.47
THRB P10828 1/20 0.47
PKM P14618 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6218489 0.90 HPGD (0.65) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA
SCHEMBL9196680 0.89 MEN1 (0.67) ALDH1A1KDM4EMAPK10USP2MAPT
SCHEMBL2611397 0.85 KDM4E (0.59) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA
SCHEMBL6243745 0.84 MAPT (0.60) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA
SCHEMBL6243893 0.83 MAPT (0.71) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA
SCHEMBL6258325 0.83 ALDH1A1 (0.56) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA
SCHEMBL6247549 0.81 MAPT (0.57) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA
SCHEMBL9760930 0.80 ADORA3 (0.56) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA
SCHEMBL6511873 0.80 HPGD (0.52) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA
SCHEMBL20988954 0.79 ALDH1A1 (0.65) ALDH1A1HPGDKDM4ESMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5037829-A Antitumor Activity; Androgen, Estrogen Inhibitors; Suppress The Plasma Elimination Of Retinoids JANSSEN PHARMACEUTICA N.V. (BE) 1991-08-06 US disclosed